Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Aurobindo Pharma: Curateq Biologics Private Limited A Wholly Owned Subsidiary Of The Company Has Mutually Agreed To Terminate Its Agreement With Biofactura Inc USA
News Announcement

Aurobindo Pharma: Curateq Biologics Private Limited A Wholly Owned Subsidiary Of The Company Has Mutually Agreed To Terminate Its Agreement With Biofactura Inc USA

27-Dec-2025 Follow Value Research Online on Google download pdfDownload PDF Aurobindo Pharma

This is to inform that Curateq Biologics Private Limited a wholly owned subsidiary of the Company has mutually agreed to terminate its agreement with BioFactura Inc. USA.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.